Skip to content

BINCHE PHARMA

Active Private limited companyfounded 2021active for 5 yearsRue de Robiano 66, 7130 BincheKBO/BCE: BE 0767.986.810

Lifetime

4 annual accounts with figures on one time axis
peak of €715,271 in 2022
€490,296▼ 11.9%
lowest -€5,516 in 2025
-€5,516▼ €55,564
peak of €102,272 in 2024
€96,756▼ 5.4%
€1.4m▼ 8.2%
peak of 5.9 FTE in 2024
5.4 FTE▼ 8.5%
Board1 name since 2021
1 director
Documentsfilings and deeds
27-08-202627 days late
2025abbreviated format
Loss of €5,516Staff from 5.9 FTE to 5.4 FTECash from €194,404 to €116,262

Key points

from the 2025 annual accounts

Result

-€5,516 -€5,516
€50,0002024-€5,5202025

From profit to loss in 2025, after a profit of €50,048 in 2024.

Turnover

≈ €1.7m estimated

The accounts state no turnover.

Debts

€1.4m 94% of the balance sheet
Financial debts 66%Suppliers 7%Taxes and wages 6%Other 21%

Of this, €478,191 falls due within a year.

Filings

4 annual accounts 3 late
AprilJune31 JulyOctober2022202320242025

The 2022 accounts came in latest, 151 days after the end of the period.

Position in the sector

6.4%

Lower solvency than 84% of companies in retail trade. The sector median is 36.9%, over 13,289 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 849 companies had the same profile as BINCHE PHARMA has now. Each dot stands for 3 companies, two years later.

91.9%
were still trading
3.3%
stopped another way
4.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a small loss

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 849 companies, not a prediction for BINCHE PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 50 sharesdeed of 26-08-2022
  • 50 sharesdeed of 26-08-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0767986810
Merger: BINCHE PHARMA takes over PHARMACIE HUBERT J.L. and PHARMACIE DAVOINE holds 50 shares · holds 50 shares · The company holds all the shares of PHARMACIE HUBERT J.L. · General meeting of 30-06-2022 · Gazette deed
Merger proposal: BINCHE PHARMA takes over PHARMACIE DAVOINE Gazette deed
Merger proposal: BINCHE PHARMA takes over PHARMACIE HUBERT J.L Gazette deed
All 15 events

Comparable companies

same main activity, similar in size and age
Company
BINCHE PHARMA Binche €1.5m €490,296 6.4% 5.4
APOTHEKE SCHUNCK Eupen €1.2m €476,638 16.5% 5.9
Beirnaert Farma Destelbergen €1.1m €526,250 31.1% 5.1
APOTHEEK NAESSENS-CLEEREN Schilde €1.1m €671,247 10.2% 4.6
PHARMACIE LAMBLIN-LAMBOT Chapelle-lez-Herlaimont €1.3m €385,076 43.8% 4
BA PHARMA Aiseau-Presles €2.2m €549,285 6.6% 5.2
PHARMACIE BERTRAND BRAIVES Braives €1.1m €547,198 21.1% 4.2

These companies have the same main activity as BINCHE PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.1m and €2.2m, founded between 2018 and 2022.

Official details

Source: KBO
Status
Active since 07-05-2021Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.317.920.5127130 Binche, since 07-05-2021
Financial year end
31 December
Peppol
Reachable since 25-11-2025
Company details

Annual accounts 2025

€1.5m▼ 8.0%
Employeeson 31-12-2025
6=
Filing
Filed on 27-08-2026
Financials

Insights on BINCHE PHARMA

BINCHE PHARMA files the abbreviated format. That format states no turnover. The gross margin fell from €715,271 in 2022 to €490,296 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BINCHE PHARMA

What is the company number of BINCHE PHARMA?
The company number of BINCHE PHARMA is 0767.986.810. The VAT number is the same number with BE in front: BE 0767.986.810.
Where is BINCHE PHARMA based?
The registered office is at Rue de Robiano 66, 7130 Binche.Company details
What does BINCHE PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of BINCHE PHARMA?
BINCHE PHARMA is a private limited company (BV).
When was BINCHE PHARMA founded?
BINCHE PHARMA was founded on 07-05-2021.
Is BINCHE PHARMA still active?
Yes, BINCHE PHARMA is an active enterprise in the KBO register.
How many employees does BINCHE PHARMA have?
BINCHE PHARMA had an average of 5.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of BINCHE PHARMA?
The turnover in financial year 2025 is about €1.7m. This figure is estimated from the gross margin of €490,296 and 42 comparable companies (NACE 477). It probably lies between €1.3m and €2.3m.
Is BINCHE PHARMA profitable?
In financial year 2025, BINCHE PHARMA made a loss of €5,516.
Where can I find the annual accounts of BINCHE PHARMA?
BINCHE PHARMA filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BINCHE PHARMA due?
BINCHE PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.